Colgate-Palmolive (NYSE:CL) Price Target Lowered to $97.00 at JPMorgan Chase & Co.

Colgate-Palmolive (NYSE:CL) had its target price lowered by equities researchers at JPMorgan Chase & Co. from $103.00 to $97.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 11.42% from the stock’s previous close.

A number of other equities analysts have also issued reports on the stock. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen dropped their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Raymond James reiterated an “outperform” rating and set a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Finally, Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Stock Up 0.4 %

Colgate-Palmolive stock traded up $0.36 during midday trading on Monday, reaching $87.06. The company’s stock had a trading volume of 3,540,313 shares, compared to its average volume of 5,274,671. The business has a 50-day simple moving average of $91.35 and a 200-day simple moving average of $97.15. The company has a market cap of $71.12 billion, a P/E ratio of 24.70, a P/E/G ratio of 3.61 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the company earned $0.87 EPS. On average, research analysts expect that Colgate-Palmolive will post 3.74 earnings per share for the current fiscal year.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 0.37% of the company’s stock.

Hedge Funds Weigh In On Colgate-Palmolive

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CL. D Orazio & Associates Inc. boosted its holdings in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after purchasing an additional 108 shares in the last quarter. Fiducient Advisors LLC increased its position in shares of Colgate-Palmolive by 5.2% during the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock worth $232,000 after purchasing an additional 110 shares in the last quarter. Sequoia Financial Advisors LLC lifted its holdings in Colgate-Palmolive by 0.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock valued at $2,117,000 after purchasing an additional 113 shares during the last quarter. Waldron Private Wealth LLC boosted its holdings in shares of Colgate-Palmolive by 2.1% in the 3rd quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock worth $585,000 after acquiring an additional 118 shares in the last quarter. Finally, Commonwealth Financial Services LLC grew its holdings in shares of Colgate-Palmolive by 4.5% during the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock worth $247,000 after purchasing an additional 118 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.